QNRX

Quoin Pharmaceuticals, Ltd. QNRX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode QNRX VRAX ONCO REVB KPRX ILAG ENSC
6M 190.88 % -41.45 % -32.83 % -85.74 % 3.38 % 76.52 % 12.32 %
YTD 2 226.14 % -70.59 % -93.57 % -95.69 % -23.18 % -30.54 % -72.36 %
1Y 2 962.75 % -64.09 % -99.32 % -96.42 % -11.29 % -39.25 % -10.59 %
3Y -23.43 % -96.29 % -99.93 % -99.99 % -95.45 % -88.22 % -99.69 %
5Y -98.82 % -99.64 % -100.00 % -100.00 % -99.80 % -89.88 % -99.99 %
10Y -99.90 % -99.64 % -100.00 % -100.00 % -99.98 % -89.88 % -99.99 %
From the beginning -99.90 % -99.64 % -100.00 % -100.00 % -99.99 % -89.88 % -99.99 %

Dividend